Source:http://linkedlifedata.com/resource/pubmed/id/17432523
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2007-4-16
|
pubmed:abstractText |
In more than one way, the development of antiparasitic vaccines is challenging, but major efforts have been made. A large number of clinical trials have been carried out and a few antigens have been tested in the endemic zone, especially against malaria. So far, no vaccine candidate has shown a sufficient and long-lasting effectiveness that would be useful for public health. However, the trials have shown without ambiguity that a certain level of clinical immunity against paludism, schistosomiasis or leishmaniasis could be induced by vaccination, in the experimental setting or in the field.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0035-2640
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
31
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
183-8
|
pubmed:meshHeading | |
pubmed:year |
2007
|
pubmed:articleTitle |
[Antiparasitic vaccines: where are we now?].
|
pubmed:affiliation |
Unité de recherche en biologie et épidémiologie parasitaires, Institut de médecine tropicale du service de santé des Armies, le Pharo, BP 46, 13998 Marseille-Armées. christophe.rogier@wanadoo.fr
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|